DE3017499A1 - Neue derivate des 5h-furan-2-ons und 3h-dihydrofuran-2-ons, verfahren zu ihrer herstellung und solche derivate enthaltende arzneimittel - Google Patents

Neue derivate des 5h-furan-2-ons und 3h-dihydrofuran-2-ons, verfahren zu ihrer herstellung und solche derivate enthaltende arzneimittel

Info

Publication number
DE3017499A1
DE3017499A1 DE19803017499 DE3017499A DE3017499A1 DE 3017499 A1 DE3017499 A1 DE 3017499A1 DE 19803017499 DE19803017499 DE 19803017499 DE 3017499 A DE3017499 A DE 3017499A DE 3017499 A1 DE3017499 A1 DE 3017499A1
Authority
DE
Germany
Prior art keywords
formula
benzyloxy
nitrobenzyloxy
chloro
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE19803017499
Other languages
German (de)
English (en)
Other versions
DE3017499C2 (cg-RX-API-DMAC7.html
Inventor
Bernard Bucher
Alain Lacour
Michel Langlois
Gisele Mocquet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthelabo SA
Original Assignee
Delalande SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7911453A external-priority patent/FR2456097A1/fr
Priority claimed from FR8007659A external-priority patent/FR2479823A2/fr
Application filed by Delalande SA filed Critical Delalande SA
Publication of DE3017499A1 publication Critical patent/DE3017499A1/de
Application granted granted Critical
Publication of DE3017499C2 publication Critical patent/DE3017499C2/de
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/58—One oxygen atom, e.g. butenolide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Furan Compounds (AREA)
DE19803017499 1979-05-07 1980-05-07 Neue derivate des 5h-furan-2-ons und 3h-dihydrofuran-2-ons, verfahren zu ihrer herstellung und solche derivate enthaltende arzneimittel Granted DE3017499A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7911453A FR2456097A1 (fr) 1979-05-07 1979-05-07 Nouveaux derives de la 5 h-furanone-2 et de la 3 h-dihydrofuranone-2, leur procede de preparation et leur application en therapeutique
FR8007659A FR2479823A2 (fr) 1980-04-04 1980-04-04 Nouveaux derives de la 5h-furanone-2 et de la 3h-dihydrofuranone-2, leur procede de preparation et leur application en therapeutique

Publications (2)

Publication Number Publication Date
DE3017499A1 true DE3017499A1 (de) 1980-11-20
DE3017499C2 DE3017499C2 (cg-RX-API-DMAC7.html) 1989-02-02

Family

ID=26221144

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19803017499 Granted DE3017499A1 (de) 1979-05-07 1980-05-07 Neue derivate des 5h-furan-2-ons und 3h-dihydrofuran-2-ons, verfahren zu ihrer herstellung und solche derivate enthaltende arzneimittel

Country Status (13)

Country Link
US (1) US4372967A (cg-RX-API-DMAC7.html)
AU (1) AU535880B2 (cg-RX-API-DMAC7.html)
BE (1) BE883124A (cg-RX-API-DMAC7.html)
CA (1) CA1136628A (cg-RX-API-DMAC7.html)
CH (1) CH647772A5 (cg-RX-API-DMAC7.html)
DE (1) DE3017499A1 (cg-RX-API-DMAC7.html)
ES (1) ES8100800A1 (cg-RX-API-DMAC7.html)
GB (1) GB2053196B (cg-RX-API-DMAC7.html)
GR (1) GR67293B (cg-RX-API-DMAC7.html)
IT (1) IT1151009B (cg-RX-API-DMAC7.html)
LU (1) LU82420A1 (cg-RX-API-DMAC7.html)
NL (1) NL8002618A (cg-RX-API-DMAC7.html)
SE (1) SE448384B (cg-RX-API-DMAC7.html)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0139206A1 (en) * 1983-09-13 1985-05-02 Mitsubishi Kasei Corporation Gamma-Butyrolactone derivatives, process for preparing the same and immunomodulating compositions containing the same as active ingredients
EP0384432A1 (en) * 1989-02-22 1990-08-29 Daiso Co., Ltd. Liquid crystalline compound and use thereof
EP0395078A1 (en) * 1989-04-28 1990-10-31 Dainippon Ink And Chemicals, Inc. Optically active lactone derivative, liquid-crystal composition, and liquid-crystal display device

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9601666D0 (en) * 1996-01-27 1996-03-27 Zeneca Ltd Chemical compounds
GB9702213D0 (en) 1996-02-24 1997-03-26 Zeneca Ltd Chemical compounds
GB9609919D0 (en) * 1996-05-11 1996-07-17 Zeneca Ltd Chemical compounds
GB9717804D0 (en) 1997-08-22 1997-10-29 Zeneca Ltd Chemical compounds
GB9717807D0 (en) 1997-08-22 1997-10-29 Zeneca Ltd Chemical compounds
GB9725244D0 (en) 1997-11-29 1998-01-28 Zeneca Ltd Chemical compounds
EP1082323A2 (en) * 1998-06-05 2001-03-14 AstraZeneca UK Limited Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them
GB9928568D0 (en) 1999-12-03 2000-02-02 Zeneca Ltd Chemical compounds
GB0009803D0 (en) * 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
J. Chem. Soc. Perkin I, 1975, S. 1480-1492 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0139206A1 (en) * 1983-09-13 1985-05-02 Mitsubishi Kasei Corporation Gamma-Butyrolactone derivatives, process for preparing the same and immunomodulating compositions containing the same as active ingredients
EP0384432A1 (en) * 1989-02-22 1990-08-29 Daiso Co., Ltd. Liquid crystalline compound and use thereof
EP0395078A1 (en) * 1989-04-28 1990-10-31 Dainippon Ink And Chemicals, Inc. Optically active lactone derivative, liquid-crystal composition, and liquid-crystal display device
US5061398A (en) * 1989-04-28 1991-10-29 Dainippon Ink And Chemicals, Inc. Optically active lactone derivative, intermediate therefor, process for producing the intermediate, liquid-crystal composition, and liquid-crystal display device

Also Published As

Publication number Publication date
GB2053196B (en) 1983-06-29
NL8002618A (nl) 1980-11-11
CA1136628A (en) 1982-11-30
US4372967A (en) 1983-02-08
GB2053196A (en) 1981-02-04
AU535880B2 (en) 1984-04-12
AU5813180A (en) 1980-11-13
CH647772A5 (fr) 1985-02-15
ES491154A0 (es) 1980-12-01
LU82420A1 (fr) 1982-01-20
ES8100800A1 (es) 1980-12-01
IT1151009B (it) 1986-12-17
SE8003228L (sv) 1980-11-08
IT8021795A0 (it) 1980-05-05
DE3017499C2 (cg-RX-API-DMAC7.html) 1989-02-02
BE883124A (fr) 1980-11-06
GR67293B (cg-RX-API-DMAC7.html) 1981-06-29
SE448384B (sv) 1987-02-16

Similar Documents

Publication Publication Date Title
DE2923295C2 (cg-RX-API-DMAC7.html)
DE2500110A1 (de) 3-aryloxy-3-phenylpropylamine und verfahren zu ihrer herstellung
DE1518002B2 (de) Isoflavane und Isoflavene und Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel
EP0095454A2 (de) Neue kernsubstituierte Pyrogallol-Derivate
DE2651572A1 (de) Aminoalkohol-derivat und verfahren zu seiner herstellung
DE3017499C2 (cg-RX-API-DMAC7.html)
EP0157267B1 (de) Substituierte Benzopyrane, Verfahren zu ihrer Herstellung sowie ihre Verwendung in Arzneimitteln
EP0005231B1 (de) Isochinolinderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
DD143908A5 (de) Verfahren zur spaltung von verbindungen
DE3586411T2 (de) Dopamin-antagoniste.
CH617689A5 (cg-RX-API-DMAC7.html)
CH617934A5 (cg-RX-API-DMAC7.html)
DE3141387C2 (cg-RX-API-DMAC7.html)
DE3320394A1 (de) Optisch aktive n-arylierte oxazolidinon-(2)-derivate, deren verwendung als spezifische und reversible inhibitoren von monoaminooxydase des b-typs sowie verfahren zu deren herstellung
DE68902946T2 (de) Heteroarotinoid-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen.
CH636076A5 (de) Benzylalkoholderivate und verfahren zu deren herstellung.
DE3823299A1 (de) Substituierte phenyl-pyrrolidin-2-one, -oxazolidin-2-one und -imidazolidin-2-one, ihre herstellung sowie verwendung in arzneimitteln
DE2653477A1 (de) Spiro eckige klammer auf cyclopropan- 1,2'-indolin eckige klammer zu -3'-one
EP0031562B1 (de) Neue Oxazoline, deren Herstellung und die neuen Oxazoline enthaltende pharmazeutische Präparate
DE2524394A1 (de) Alpha-aminomethyl-3-aethyl-4-hydroxybenzylalkoholderivate, verfahren zu ihrer herstellung und arzneimittel
DE1543653C3 (de) Basisch substituierte Benzofuranderivate und deren pharmazeutisch verträgliche Säureadditionssalze sowie Verfahren zu deren Herstellung und Arzneimittel mit einem Gehalt dieser Verbindungen
DE2710807C2 (de) Benzylamino-alkancarboxamide, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
AT381088B (de) Verfahren zur herstellung von neuen aminen und deren salzen
DE1815467C3 (de) 4- [Ortho-(2"3"- dihydroxypropyloxycarbonyl)phenyl] -amino-8-trifluormethylchinolin und seine Salze und Arzneimittel
AT234687B (de) Verfahren zur Herstellung von neuen Benzodioxanderivaten, sowie von deren Säureadditionssalzen

Legal Events

Date Code Title Description
8181 Inventor (new situation)

Free format text: LANGLOIS, MICHEL, BUC, FR LACOUR, ALAIN, LA VARENNE, FR BUCHER, BERNARD, MARNES LA COQUETTE, FR MOCQUET, GISELE, PARIS, FR

8128 New person/name/address of the agent

Representative=s name: GRUENECKER, A., DIPL.-ING. KINKELDEY, H., DIPL.-IN

8110 Request for examination paragraph 44
8128 New person/name/address of the agent

Representative=s name: GRUENECKER, A., DIPL.-ING. KINKELDEY, H., DIPL.-IN

D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee